Piper Sandler Reiterates Overweight Rating on Sutro Biopharma (STRO)
Go back to Piper Sandler Reiterates Overweight Rating on Sutro Biopharma (STRO)| (NASDAQ: STRO) | Delayed: 25.29 +2.79 (12.40%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.50 | 52 Week High | $ | |||
| Open | $22.21 | 52 Week Low | $ | |||
| Day High | $25.68 | P/E | N/A | |||
| Day Low | $22.21 | EPS | $ | |||
| Volume | 264,823 | |||||

